Reducing Your 'Bioenergetic Age' May Ward Off Alzheimer's, Study Finds
Your risk of developing Alzheimer's disease depends largely on your genes and your age, but that doesn't mean it's out of your hands. As a new study suggests, you might have more influence on the matter than you think.
The study's authors introduce another key indicator for Alzheimer's risk that may warrant more attention: your 'bioenergetic age', which isn't necessarily the same as your chronological age.
Bioenergetics is a field of biochemistry focused on the transformation of energy in living things. Your bioenergetic age represents how efficiently (i.e., how youthfully) your cells generate energy.
This metric may not only improve the accuracy of Alzheimer's risk assessments, the study finds, but could also help empower patients to mitigate their own risk. While bioenergetic age is dictated partly by genes and the passage of time, it's malleable in ways chronological age is not.
Previous research suggests that some people can reduce their bioenergetic age with healthy habits like physical activity. A simulated clinical trial conducted as part of the recent study showed that improving bioenergetic age may even curb the progression of Alzheimer's as effectively as lecanemab, a drug for treating the disease.
"That's quite big because it means some people can lower their risk without the uncertain side effects of current treatments," says senior author Jan Krumsiek, physiologist at Weill Cornell Medicine.
It may also help explain why Alzheimer's can progress so differently in people with similar early signs of the disease, like cells that begin using and producing energy less efficiently.
While many people with this warning sign soon develop Alzheimer's symptoms, others mysteriously remain symptom-free for years.
A special 'bioenergetic capacity' seems to protect these patients, helping them maintain normal energy levels despite pathological anomalies in their energy pathways, the researchers write.
"In these cases, people can be unusually healthy when we look at their cognition," Krumsiek says. "They make it to old age without the kind of declines that usually creep in."
The next step was to find a test that can identify which patients already have this higher bioenergetic capacity, and a way to cultivate it in those where it's lower.
The researchers focused on a class of fatty acid metabolites known as acylcarnitines found in the blood, which previous studies have established as markers of cognitive decline and energy metabolism.
Using data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), they investigated whether acylcarnitine levels in blood can clarify Alzheimer's risk.
Higher acylcarnitine levels correlate with a higher bioenergetic age, which is associated with more severe Alzheimer's pathology and cognitive decline, the study found.
The researchers used a common 11-question test to assess cognitive decline, finding patients with low acylcarnitine levels declined less quickly, losing about half a point less per year than patients with high acylcarnitine levels.
That rate is comparable to that of patients taking lecanemab, they add, suggesting that having a lower bioenergetic age could be protective against Alzheimer's.
"It was fascinating," Krumsiek says. "Dividing research participants into groups based on their specific acylcarnitine levels highlighted people with more severe Alzheimer's disease and others with fewer symptoms."
This suggests acylcarnitines can help us read our bioenergetic clocks, revealing how old we seem based on our metabolism rather than the date of our birth. Luckily, a cheap test for acylcarnitine levels in blood already exists.
"It's fortunate that these blood tests – originally developed to identify metabolic and mitochondrial disorders in newborns – can also help assess a person's bioenergetic age," Krumsiek says.
"If we can repurpose this technology for older adults, that could provide a way to start personalized treatment earlier."
That treatment could include behavioral shifts to boost exercise and nutrition, reducing patients' bioenergetic age and thus their Alzheimer's risk.
Interventions like these might yield the most benefit for patients with a high bioenergetic age but also a favorable genetic profile, the researchers suggest, noting that about 30 percent of participants from the ADNI study fit that description.
Future research should also explore which interventions are most effective in reducing a person's bioenergetic age, the researchers say.
The study was published in Nature Communications.
Exercise Boosts Brain Function Across All Ages, Massive Study Confirms
Pouring Coffee Into Your Rectum Isn't Worth The Risk, Says Expert
Oral Cancer Cases Are on The Rise, And Sugary Drinks Could Be to Blame
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
39 minutes ago
- Yahoo
Broome County educating seniors and caregivers on Alzheimer's
BROOME COUNTY, N.Y. (WIVT/WBGH) – Older adults can join Broome County in learning more about Alzheimer's. The Broome County Office for Aging and the Alzheimer's Association are hosting a presentation on 'Exploring Care and Support Services' at the Johnson City Senior Center on June 17 from 1 to 2 p.m. This is one part of the Alzheimer's Association's 'Empowered Caregiver Series.' The presentation will walk caregivers through different types of respite, both long-term and residential, how to plan for these changes, and end-of-life care options. Additional parts of the series will be held in upcoming months. You do not have to attend allparts of the series. To register for the event, call the Office for Aging at (607) 778-2411 and ask to speak with Megan. Hanagan's Heroes monument to be relocated to Southside Veterans Park Broome County educating seniors and caregivers on Alzheimer's Binghamton man sentenced for threatening victim from jail Riley supporting loan forgiveness for volunteer first responders P. East Trading Corp recalls Salted Smoked Split Herring Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
3 hours ago
- Yahoo
Senators grill NIH director on massive budget cuts
National Institutes of Health Director Dr. Jay Bhattacharya faced critical questions from both Republican and Democratic senators Tuesday as he sought to defend the Trump administration's sweeping plans to reorganize the agency and slash budgets for medical research. Senate Appropriations Chairwoman Susan Collins (R-ME) swiftly criticized the current budget cuts and proposed changes, including a nearly 40% reduction to the National Institute of Aging's spending and 40% overall cuts to the agency's institutes. 'As the senator representing … the oldest state in the nation, this is a particular concern,' Collins said. 'I know personally what it means to so many American families.' The senator also said caps on indirect spending for universities are 'so poorly conceived' and have harmed U.S. medical research. 'It is leading to scientists leaving the United States for opportunities in other countries. It's causing clinical trials to be halted and promising medical research to be abandoned.' A federal court has paused the 15% cap on payments for indirect costs, but the administration assumed savings from the change in its 2026 fiscal year budget. Bhattacharya defended certain administrative changes while distancing himself from others, such as a pause on Northwestern University's grant funding, saying certain terminations happened before he assumed his role. In answering Sen. Tammy Baldwin (D-WI) about overall cuts, Bhattacharya took responsibility for other sweeping grant cancellations. 'There's changes in priorities at the NIH to move away from politicized science, I made those decisions,' he said. The hearing room was filled with purple-garbed advocates for Alzheimer's disease research and representatives of the American Cancer Society Cancer Action Network dressed in light blue. Baldwin harshly criticized the proposed $18 billion reduction to the NIH's total spending, saying cuts will resonate as the NIH funds 15,000 fewer medical research projects. 'While I think Congress will reject your budget request, it clearly shows the administration's intent,' Baldwin said. 'How is this proposal anything but intentionally sabotaging biomedical research?' Bhattacharya said he is 'happy to work with Congress' on the budget and more flexible spending on medical research.
Yahoo
4 hours ago
- Yahoo
Get Ready to Hear a Lot More About Your Mitochondria
The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here. Robert F. Kennedy Jr.'s warning about mitochondria slipped in between the anti-vaccine junk science and the excoriation of pharmaceutical drugs as 'the No. 3 killer in our country.' He was speaking in 2023 to Joe Rogan, elaborating on the dangers of Wi-Fi—which no high-quality scientific evidence has shown to harm anyone's health—and arguing that it causes disease by somehow opening the blood-brain barrier, and by degrading victims' mitochondria. The mention of mitochondria—the tiny structures that generate energy within our cells—was brief. Two years later, mitochondrial health is poised to become a pillar of the MAHA movement, already showing up in marketing for supplements and on podcasts across the 'manosphere.' Casey Means, President Donald Trump's newest nominee for surgeon general, has singled out the organelle as the main casualty of the modern American health crisis. According to Means (who has an M.D. but no active medical license), most of America's chronic ailments can be traced to mitochondrial dysfunction. Should she be confirmed to the post of surgeon general, the American public can expect to hear a lot more about mitochondria. Among scientists, interest and investment in mitochondria have risen notably in the past five years, Kay Macleod, a University of Chicago researcher who studies mitochondria's role in cancer, told me. Mitochondria, after all, perform a variety of crucial functions in the human body. Beyond powering cells, they can affect gene expression, help certain enzymes function, and modulate cell death, Macleod said. When mitochondria are defective, people do indeed suffer. Vamsi Mootha, a mitochondrial biologist based at Massachusetts General Hospital and the Broad Institute, told me that rare genetic defects (appearing in about one in 4,300 people) can cause the organelles to malfunction, leading to muscle weakness, heart abnormalities, cognitive disability, and liver and kidney problems. Evidence also suggests that defects in mitochondria directly contribute to symptoms of Parkinson's disease, and could be both a cause and an effect of type 2 diabetes. Other conditions' links to mitochondria are blurrier. Researchers see aberrant mitochondria in postmortem biopsies of patients with illnesses such as Alzheimer's, cancer, and fatty-liver disease, Mootha said; whether those damaged mitochondria cause or result from such conditions is not yet clear. But according to Good Energy, the book Means published last year with a top MAHA adviser—her brother, Calley—mitochondrial dysfunction is a veritable plague upon the United States, responsible for both serious illness and everyday malaise. In their view, modern Western diets and lifestyles wreck countless Americans' metabolic health: Every time you drink unfiltered water or a soda, or feel the stress of mounting phone notifications, you hurt your mitochondria, they say, triggering an immune response that in turn triggers inflammation. (Damaged mitochondria really can cause inflammation, Macleod said.) This chain of events, the Meanses claim, can be blamed for virtually every common chronic health condition: migraines, depression, infertility, heart disease, obesity, cancer, and more. (Casey Means did not respond to requests for comment; reached by email, Calley did not respond to my questions about mitochondria, but noted, 'There is significant scientific evidence that healthy food, exercise and sleep have a significant impact on reversing chronic disease.') Good Energy follows a typical wellness playbook: using a mixture of valid and dubious research to pin a slew of common health problems on one overlooked element of health—and advertising a cure. Among the culprits for our mitochondrial ravaging, according to the Meanses, are poor sleep, medications, ultraprocessed foods, seed oils, too many calories, and too few vitamins, as well as chronically staying in comfortable ambient temperatures. The Means siblings therefore recommend eschewing refined sugar in favor of leafy greens, avoiding nicotine and alcohol, frequenting saunas and cold plunges, getting seven to eight hours of uninterrupted sleep a night, and cleansing your life of environmental toxins. Some studies indeed suggest that mitochondrial function is linked with sleep and temperature, but they've all been conducted on cell cultures, organoids, or mice. According to Macleod, evidence suggests that diet, too, is likely important. But only one lifestyle intervention—exercise—has been definitively shown to improve mitochondrial health in humans. The Meanses are riding a wave of interest in mitochondrial health in the wellness world. Earlier this year, the longevity influencer Bryan Johnson and the ivermectin enthusiast Mel Gibson both endorsed the dye methylene blue for its power to improve mitochondrial respiration; Kennedy was filmed slipping something that looks a lot like methylene blue into his drink. (Kennedy did not respond to a request for comment; the FDA has approved methylene blue, but only as a treatment for the blood disease methemoglobinemia.) AG1, formerly known as Athletic Greens, formulates its drinkable vitamins for mitochondrial health. Even one laser-light skin treatment promises to 'recharge failing mitochondria.' The enzyme CoQ10 is popular right now as a supplement for mitochondrial function, as is NAD, a molecule involved in mitochondria's production of energy. NAD IV drips are especially beloved by celebrities such as Gwyneth Paltrow, Kendall Jenner, and the Biebers. These supplements are generally thought to be safe, and some preliminary research shows that NAD supplementation could help patients with Parkinson's or other neurodegenerative diseases, and that CoQ10 could benefit people with mitochondrial disorders. Patients whose symptoms are clearly caused or made worse by deficiencies in a specific vitamin, such as thiamine, can benefit from supplementing those vitamins, Mootha said. But little research explores how these supplements might affect healthy adults. [Read: The MAHA takeover is complete] In Good Energy, as well as on her website and in podcast appearances, Casey Means promotes a number of supplements for mitochondrial health. She also recommends that people wear continuous glucose monitors—available from her company, Levels Health, for $184 a month—to help prevent overwhelming their mitochondria with too much glucose. (According to Macleod, glucose levels are only 'a very indirect measure' of mitochondrial activity.) As with so many problems that wellness influencers harp on, the supposed solution to this one involves buying products from those exact same people. At best, all of this attention to mitochondria could lead Americans to healthier habits. Much of the advice in Good Energy echoes health recommendations we've all heard for decades; getting regular exercise and plenty of fiber is good guidance, regardless of anyone's reasons for doing so. Switching out unhealthy habits for healthy ones will likely even improve your mitochondrial health, Jaya Ganesh, a mitochondrial-disease expert at Icahn School of Medicine at Mount Sinai, told me. After all, 'if you consistently beat your body up with unhealthy habits, everything is going to fall sick,' Ganesh said. But the mitochondrial approach to wellness carries risks, too. For patients with genetically caused mitochondrial disease, lifestyle changes might marginally improve some symptoms, Ganesh said, but attempting to cure such conditions with supplements and a healthy diet alone could be dangerous. Means also calls out medications—including antibiotics, chemotherapy, antiretrovirals, statins, and high-blood-pressure drugs—for interfering with mitochondria. Macleod told me that statins really do affect mitochondria, as do some antibiotics. (The latter makes sense: Mitochondria are thought to have evolved from bacteria more than a billion years ago.) That's no reason, though, to avoid any of these medications if a doctor has determined that you need them. [Read: America can't break its wellness habit] And yet, a whole chapter of Good Energy is dedicated to the idea that readers should mistrust the motives of their doctors, who the authors say profit by keeping Americans sick. The book is less critical of the ways the wellness industry preys on people's fears. Zooming in on mitochondria might offer a reassuringly specific and seemingly scientific explanation of the many real ills of the U.S. population, but ultimately, Means and MAHA are only helping obscure the big picture. Article originally published at The Atlantic
